The risk of PD-L1 expression misclassification in triple-negative breast cancer.
Shani Ben DoriAsaf AizicAsia ZubkovShlomo TsurielEdmond SaboDov HershkovitzPublished in: Breast cancer research and treatment (2022)
Our model can be used to estimate the risk of PD-L1 misclassification in biopsies, with potential implications for treatment decisions.